PBYI
PBYI
US74587V1070
Puma Biotechnology Inc
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 90/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±75.8% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.2x as much as the broader market.

Beta (Market Relation)
1.21x
Above average
Volatility (5Y p.a.)
75.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-75.1%
5-Year Horizon
Sharpe Ratio
0.10
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +90.6%
3 Years 70.5% -69.6% 0.85 +62.3%
5 Years 75.8% -75.1% 0.1 +10.3%
10 Years 79.9% -98.8% -0.24 -16.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (75.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -98.8% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
6 ISS Score: 6 / 10
Board Risk
6 ISS Score: 6 / 10
Short Ratio
14.60
ende